Hernandez-Barrueta Tana, Amaya-Llano Silvia Lorena, Nitin Nitin
Department of Food Science and Technology, University of California, Davis, California, USA.
Posgrado de Alimentos, Universidad Autonoma de Queretaro, Santiago de Queretaro, Queretaro, Mexico.
Appl Environ Microbiol. 2025 Jul 23;91(7):e0024825. doi: 10.1128/aem.00248-25. Epub 2025 Jun 12.
Preserving the viability of probiotics during storage and gastrointestinal digestion poses a significant challenge in the development of effective probiotic formulations. Thus, this study developed an fermentation approach to encapsulate the probiotic GG (LGG) in a mixed whey protein/modified starch gel and evaluated (i) the role of the pili on gel formation and on the effectiveness of the gel to maintain cell viability during simulated digestion, and (ii) the storage stability of the encapsulated probiotics. Kinetic data of gels made with the wild-type (WT) or a pilus-depleted mutant (Δ) strain showed a rapid gel formation (<30 min) at room temperature after inoculating the polymeric mixture, driven by fermentation and independently of the piliation of the cells. After simulated gastrointestinal digestion, the viability of encapsulated WT cells was ~3 log higher than free WT cells ( value 7 × 10) and ~0.6 times higher than encapsulated Δ cells ( value 9 × 10). A higher release of Δ vs WT cells from the gels was quantified, and confocal microscopy revealed the aggregation of Δ but not WT cells within the gel cavities. These findings suggest the pili-dependent retention of LGG within the gel contributes to its protective effect. Finally, the hydrated gels sustained counts of LGG of 7.76-6.69 log CFU/g (depending on the relative humidity) during 2 months of storage at room temperature. In summary, bacteria-to-matrix interactions might influence the survival of probiotics during delivery, and the protein/starch gels could represent a cost-effective alternative for unrefrigerated storage and delivery of probiotics.
Many probiotic formulations struggle to maintain the viability of microbial cells over time and during their passage through the gastrointestinal tract. This has led to the development of encapsulation strategies for probiotics, most of which are either costly to implement or damage the cells during the encapsulation process. To overcome these limitations, this work developed a rapid fermentation-based approach to encapsulate probiotics in protein/starch gels as a strategy to keep the cells alive during storage and digestion. Moreover, this work explored the role of interactions between bacterial cells and their encapsulation matrix on the formation of the gels and in the protection the gels provided in maintaining the viability of cells during simulated digestion. Developing this fermentation approach for the encapsulation of probiotics and understanding the bacteria-matrix interactions will lead to the development of more effective probiotic products that can be easily deployed in low-resource settings.
在有效的益生菌制剂开发过程中,保持益生菌在储存和胃肠道消化过程中的活力是一项重大挑战。因此,本研究开发了一种发酵方法,将益生菌鼠李糖乳杆菌GG(LGG)封装在混合乳清蛋白/改性淀粉凝胶中,并评估了(i)菌毛在凝胶形成以及在模拟消化过程中凝胶保持细胞活力有效性方面的作用,以及(ii)封装后益生菌的储存稳定性。用野生型(WT)或菌毛缺失突变株(Δ)制成的凝胶动力学数据表明,接种聚合物混合物后,在室温下凝胶快速形成(<30分钟),这是由发酵驱动的,与细胞的菌毛化无关。经过模拟胃肠道消化后,封装的WT细胞活力比游离WT细胞高约3个对数(数值为7×10),比封装的Δ细胞高约0.6倍(数值为9×10)。定量分析显示,与WT细胞相比,Δ细胞从凝胶中的释放量更高,共聚焦显微镜显示凝胶腔内有Δ细胞聚集,但没有WT细胞聚集。这些发现表明,LGG在凝胶中依赖菌毛的保留有助于其保护作用。最后,在室温下储存2个月期间,水合凝胶中LGG的活菌数维持在7.76 - 6.69 log CFU/g(取决于相对湿度)。总之,细菌与基质的相互作用可能会影响益生菌在递送过程中的存活,并且蛋白质/淀粉凝胶可能是益生菌非冷藏储存和递送的一种经济有效的替代方法。
许多益生菌制剂难以在长时间以及通过胃肠道的过程中维持微生物细胞的活力。这导致了益生菌封装策略的发展,其中大多数要么实施成本高昂,要么在封装过程中会损害细胞。为了克服这些限制,本研究开发了一种基于快速发酵的方法,将益生菌封装在蛋白质/淀粉凝胶中,作为在储存和消化过程中保持细胞存活的策略。此外,本研究探讨了细菌细胞与其封装基质之间的相互作用在凝胶形成以及凝胶在模拟消化过程中保持细胞活力所提供的保护方面的作用。开发这种用于封装益生菌的发酵方法并理解细菌 - 基质相互作用将有助于开发更有效的益生菌产品,这些产品可以在资源匮乏的环境中轻松应用。